Table 2.
Maximum platelet aggregation and hemolysis after blood contact with modified and unmodified biodegradable prostheses.
| Sample | Maximum Platelet Aggregation, % Me (25–75%) |
Hemolysis, % Me (25–75%) |
|---|---|---|
| PHBV/PCL | 87.23 (83.95–89.84) * | 0.5 (0.0–1.0) |
| PCL | 87.23 (83.27–89.35) * | 0.5 (0.0–1.0) |
| PHBV/PCL/PVP | 88.53 (86.59–89.37) * | 0.2 (0.0–0.5) |
| PCL/PVP | 90.12 (82.57–90.60) * | 0.7 (0.5–1.0) |
| PHBV/PCL/PVP/Ilo/A | 12.18 (11.15–12.24) *,** | 0.5 (0.0–0.5) |
| PCL/PVP/Ilo/A | 10.7 (10.38–17.23) *,** | 0.4 (0.0–1.0) |
| Platelet-rich plasma | 74.65 (72.45–75.31) | - |
Note: *—p < 0.05 in comparison with platelet-rich plasma; **—p < 0.05 in comparison with PHBV/PCL or PCL. Data are presented as the median (Me) and interquartile range (25–75%).